Results 241 to 250 of about 73,970 (344)

First birth and total fertility rate in women with surgically verified endometriosis – A nationwide register study of 18 320 women across reproductive life course

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Our national population‐based study covering the reproductive life course found that women with surgically verified endometriosis had a lower probability of first birth irrespective of endometriosis subtype. Abstract Introduction Endometriosis is associated with pain and infertility.
Anni Tuominen   +6 more
wiley   +1 more source

Medical treatment prior to micro-TESE. [PDF]

open access: yesAsian J Androl
Dasgupta S   +4 more
europepmc   +1 more source

Recurrent Goiter, Hyperthyroidism, Galactorrhea and Amenorrhea due to a Thyrotropin ans Prolactin-Producing Pituitary Tumor [PDF]

open access: yes, 1976
Erhardt, F.   +5 more
core   +1 more source

Treatment With Inhaled Nitric Oxide and General Intelligence in Preterm Children in Two European Cohorts

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To investigate whether treatment with inhaled nitric oxide is associated with cognitive performance at age 5–6 years in preterm‐born children. Methods We analysed preterm children from two large European cohort studies, the German Neonatal Network (GNN) (N = 3606) and the French EPIPAGE‐2 cohort (N = 2579) admitted to neonatal care and ...
Nicole Tsalacopoulos   +12 more
wiley   +1 more source

Ovarian tachykinin signaling system induces the growth of secondary follicles during the gonadotropin-independent process. [PDF]

open access: yesJ Biol Chem
Kawada T   +9 more
europepmc   +1 more source

Group Experiments on the Radioimmunological Insulin Determination [PDF]

open access: yes, 1974
Bottermann, P.   +8 more
core   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

Reduction in minipubertal gonadotropin levels alters reproductive lifespan and ovarian follicular loss in female mice. [PDF]

open access: yesHum Reprod
Chester M   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy